Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients
Status:
Withdrawn
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
Our objective is to assess whether pre-treatment with a fixed dose of insulin, based on
weight, given to pregnant patients with gestational or preexisting diabetes receiving
betamethasone can provide adequate glycemic control.
Our hypothesis is that pre-treatment with a weight-based calculated insulin dose will help
maintain euglycemia for pregnant patients with gestational and preexisting diabetes after
steroid administration, and possibly impact length of hospital admission.
Phase:
Phase 4
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute